We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Registrations Open for 2022 AACC Annual Scientific Meeting & Clinical Lab Expo

By LabMedica International staff writers
Posted on 02 Mar 2022
Print article
Image: Expo only registration is open for 2022 AACC Clinical Lab Expo (Photo courtesy of AACC)
Image: Expo only registration is open for 2022 AACC Clinical Lab Expo (Photo courtesy of AACC)

The American Association for Clinical Chemistry (AACC Washington, D.C., USA) has announced that Expo only registration is now open for the Annual Scientific Meeting & Clinical Lab Expo for those who wish to be in-the-know as exhibitors roll out the latest technologies and services.

The 2022 AACC Annual Scientific Meeting & Clinical Lab Expo will be held at the McCormick Place Convention Center in Chicago, USA on July 24-28, 2022. The event will bring together the global laboratory medicine community for AACC's world-renowned exposition of clinical laboratory products and services. At the event, attendees will have the opportunity to connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

As the place to learn about breakthrough innovations from industry leaders, AACC’s Clinical Lab Expo gives attendees the opportunity to explore new advances that ignite the collective passion for discovery and practical solutions that fit the lab’s needs. The AACC Clinical Lab Expo has more than 200 new product introductions each year, allowing attendees to learn about cutting edge technology. In addition, attendees can hear vital research and learn about important changes in the field. With more than 250 educational opportunities in the form of lectures, plenary sessions, scientific sessions, and roundtable sessions, they can design an educational experience that meets their need to stay ahead of changes in the field. Those interested can join the global laboratory medicine community for AACC's world-renowned exposition of clinical laboratory products and services for a registration fee of just USD 10.

Related Links:
AACC 

Gold Supplier
Chromogenic Medium
CHROMagar Candida Plus
New
Chemiluminescence Analyzer
DZ-Lite 3000 Plus
New
Gold Supplier
Automatic Biochemistry Analyzer
Biossays C8
New
Benchtop Centrifuge & Vortexer
ExiSpin

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more

Hematology

view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.